First-Line Maintenance Therapy Patterns in BRCA Wild-Type, HRD-Negative or Biomarker-Unknown Advanced Epithelial Ovarian Cancer: A Five-Country European Real-World Study by APLUSA.

Simple Summary: Many women with advanced epithelial ovarian cancer do not have a biomarker to guide treatment decisions after initial chemotherapy. In this situation, doctors may choose different post-chemotherapy strategies depending on patient factors, local practice and national access to medicin...

Descripción completa

Detalles Bibliográficos

Publicado en:	Cancers Vol. 18; no. 16; pp. 2682 - 2695
Autores principales:	Uccello, Mario, Boussios, Stergios, Maï, Christine, Worton, Hilary, Bazire, Arthur, de Buhren, Bertrand
Formato:	research tables/charts Journal Article
Publicado:	MDPI Aug2026
Acceso en línea:	Ver este registro en EBSCOhost